Schedule 13G ownership disclosure

Beta Bionics Inc

Common Stock, $0.0001 par value per share (the "Shares") · CUSIP: 08659B102

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Zone Healthcare Holdings, LLC

    Shares: 3,277,220 · Class: 7.6%

  • Farallon Capital Partners, L.P.

    Shares: 166,877 · Class: 0.4%

  • Farallon Capital Institutional Partners, L.P.

    Shares: 169,691 · Class: 0.4%

  • Farallon Capital Institutional Partners II, L.P.

    Shares: 63,840 · Class: 0.1%

  • Farallon Capital Institutional Partners III, L.P.

    Shares: 43,138 · Class: 0.1%

  • Four Crossings Institutional Partners V, L.P.

    Shares: 42,216 · Class: 0.1%

  • Farallon Capital Offshore Investors II, L.P.

    Shares: 380,597 · Class: 0.9%

  • Farallon Capital (AM) Investors, L.P.

    Shares: 26,029 · Class: 0.1%

  • Farallon Capital F5 Master I, L.P.

    Shares: 34,312 · Class: 0.1%

  • Farallon Capital Management, L.L.C.

    Shares: 3,277,220 · Class: 7.6%

  • Farallon Partners, L.L.C.

    Shares: 892,388 · Class: 2.1%

  • Farallon F5 (GP), L.L.C.

    Shares: 34,312 · Class: 0.1%

  • Farallon Institutional (GP) V, L.L.C.

    Shares: 42,216 · Class: 0.1%

  • Dapice Joshua J.

    Shares: 4,203,920 · Class: 9.7%

  • Dreyfuss, Philip D.

    Shares: 4,203,920 · Class: 9.7%

  • Dunn Hannah E.

    Shares: 4,203,920 · Class: 9.7%

  • Fried, Richard B

    Shares: 4,203,920 · Class: 9.7%

  • Gehani, Varun N.

    Shares: 4,203,920 · Class: 9.7%

  • Giauque, Nicolas

    Shares: 4,203,920 · Class: 9.7%

  • Kim, David T.

    Shares: 4,203,920 · Class: 9.7%

  • Linn, Michael G.

    Shares: 4,203,920 · Class: 9.7%

  • Luo Patrick (Cheng)

    Shares: 4,203,920 · Class: 9.7%

  • Patel, Rajiv A.

    Shares: 4,203,920 · Class: 9.7%

  • Roberts, Jr., Thomas G.

    Shares: 4,203,920 · Class: 9.7%

  • Saito Edric C.

    Shares: 4,203,920 · Class: 9.7%

  • Seybold, William

    Shares: 4,203,920 · Class: 9.7%

  • Short Daniel S.

    Shares: 4,203,920 · Class: 9.7%

  • Spokes, Andrew J. M.

    Shares: 4,203,920 · Class: 9.7%

  • Warren, John R.

    Shares: 4,203,920 · Class: 9.7%

  • Wehrly, Mark C.

    Shares: 4,203,920 · Class: 9.7%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000908834-25-000241
Form type
SCHEDULE 13G/A
Filer
Beta Bionics, Inc.
CIK
CIK 1674632
Filed
Aug 13, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub